Socio-Economic Status Determines Risk of Receptive Syringe Sharing Behaviors Among Iranian Drug Injectors; A National Study

Overview

Journal Front Psychiatry

Specialty Psychiatry

Date 2015 Apr 9

PMID 25852577

Citations 6

Authors

Shervin Assari

Khodabakhsh Ahmadi

Majid Rezazade

Affiliations

Soon will be listed here.

Abstract

Background: Although needle and syringe sharing is one of the main routs of transmission of HIV in several countries in the middle east, very little is known about how socio-economic status of injecting drug users (IDUs) is linked to the receptive syringe sharing behaviors in these countries.

Aim: To study socio-economic correlates of receptive needle and syringe sharing among IDUs in Iran.

Methods: The study used data from the Unhide Risk Study, a national survey of IDUs. This study sampled 636 IDUs (91% male) via snowball sampling from eight provinces in Iran in 2009. Socio-demographic and drug use characteristics were collected. We used a logistic regression to determine factors associated with receptive needle and syringe sharing during the past 6 months.

Results: From 636 IDUs enrolled in this study, 68% (n = 434) reported receptive needle and syringe sharing behaviors in the past 6 months. Odds of receptive needle and syringe sharing in the past 6 months was lower among IDUs who were male [odds ratios (OR) = 0.29, 95% confidence interval (CI) = 0.12-0.70], had higher education (OR = 0.74, 95% CI = 0.64-0.86) but higher among those who were unemployed (OR = 4.05, 95% CI = 1.50-10.94), and were single (OR = 1.47, 95% CI = 1.02-2.11).

Conclusion: This study presented factors associated with risk of receptive needle and syringe sharing among Iranian IDUs. This information may be used for HIV prevention and harm reduction purposes. Socio-economic status of Iranian IDUs may be closely linked to high-risk injecting behaviors among them.

Citing Articles

Pattern of contributing behaviors and their determinants among people living with HIV in Iran: A 30-year nationwide study.

Gheibi Z, Fararouei M, Afrashteh S, Akbari M, Kazerooni P, Shokoohi M Front Public Health. 2023; 11:1038489.

PMID: 36908430 PMC: 9998994. DOI: 10.3389/fpubh.2023.1038489.

Changing Pattern of Opioid Users Attending an Opioid Agonist Treatment Clinic in North India.

Bhat F, Rather Y, Rasool U J Neurosci Rural Pract. 2022; 13(2):176-180.

PMID: 35694070 PMC: 9187399. DOI: 10.1055/s-0041-1736509.

A qualitative study to understand drivers of psychoactive substance use among Nepalese youth.

Bhandari T, Khatiwada B, Rajbhandari B, Bestman A, Mistry S, Rayamajhee B PLoS One. 2021; 16(11):e0259021.

PMID: 34739508 PMC: 8570474. DOI: 10.1371/journal.pone.0259021.

Income Gradient in Renal Disease Mortality in the United States.

Assari S, Lankarani M Front Med (Lausanne). 2017; 4:190.

PMID: 29164123 PMC: 5681740. DOI: 10.3389/fmed.2017.00190.

Access to treatment for Hepatitis C among injection drug users: results from the cross-sectional HOPE IV study.

Souliotis K, Agapidaki E, Papageorgiou M, Voudouri N, Contiades X Int J Equity Health. 2017; 16(1):101.

PMID: 28615023 PMC: 5471999. DOI: 10.1186/s12939-017-0601-3.

References

Mirabi P, Vasel M, Moazen B, Sehat M, Rezazadeh M, Ahmadi K . Unprotected anal Intercourse among Iranian Intra-Venous Drug Users. Front Public Health. 2013; 1:34. PMC: 3859981. DOI: 10.3389/fpubh.2013.00034. View

Schisterman E, Cole S, Platt R . Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology. 2009; 20(4):488-95. PMC: 2744485. DOI: 10.1097/EDE.0b013e3181a819a1. View

Zamani S, Radfar R, Nematollahi P, Fadaie R, Meshkati M, Mortazavi S . Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran. Int J Drug Policy. 2010; 21(6):493-500. DOI: 10.1016/j.drugpo.2010.04.006. View

Sofian M, Aghakhani A, Banifazl M, Azadmanesh K, Farazi A, McFarland W . Viral hepatitis and HIV infection among injection drug users in a central Iranian City. J Addict Med. 2012; 6(4):292-6. DOI: 10.1097/ADM.0b013e3182659928. View

Gheiratmand R, Navipour R, Mohebbi M, Mallik A . Uncertainty on the number of HIV/AIDS patients: our experience in Iran. Sex Transm Infect. 2005; 81(3):279-80. PMC: 1744973. DOI: 10.1136/sti.2004.012880. View

Rahimi-Movaghar A, Razaghi E, Sahimi-Izadian E, Amin-Esmaeili M . HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran. Int J Infect Dis. 2009; 14(1):e28-33. DOI: 10.1016/j.ijid.2009.03.002. View

Alipour A, Haghdoost A, Sajadi L, Zolala F . HIV prevalence and related risk behaviours among female partners of male injecting drugs users in Iran: results of a bio-behavioural survey, 2010. Sex Transm Infect. 2013; 89 Suppl 3:iii41-4. PMC: 3841763. DOI: 10.1136/sextrans-2013-051201. View

M Razzaghi E, Movaghar A, Green T, Khoshnood K . Profiles of risk: a qualitative study of injecting drug users in Tehran, Iran. Harm Reduct J. 2006; 3:12. PMC: 1431517. DOI: 10.1186/1477-7517-3-12. View

Todd C, Abed A, Scott P, Botros B, Safi N, Earhart K . Correlates of receptive and distributive needle sharing among injection drug users in Kabul, Afghanistan. Am J Drug Alcohol Abuse. 2007; 34(1):91-100. DOI: 10.1080/00952990701764771. View

10.

Razani N, Mohraz M, Kheirandish P, Malekinejad M, Malekafzali H, Mokri A . HIV risk behavior among injection drug users in Tehran, Iran. Addiction. 2007; 102(9):1472-82. DOI: 10.1111/j.1360-0443.2007.01914.x. View

11.

Zamani S, Vazirian M, Nassirimanesh B, Razzaghi E, Ono-Kihara M, Ravari S . Needle and syringe sharing practices among injecting drug users in Tehran: a comparison of two neighborhoods, one with and one without a needle and syringe program. AIDS Behav. 2008; 14(4):885-90. DOI: 10.1007/s10461-008-9404-2. View

12.

Assari S . Over-adjustment bias by controlling for overall health. Int J Prev Med. 2013; 4(4):491-2. PMC: 3650604. View

13.

Magis-Rodriguez C, Brouwer K, Morales S, Gayet C, Lozada R, Ortiz-Mondragon R . HIV prevalence and correlates of receptive needle sharing among injection drug users in the Mexican-U.s. border city of Tijuana. J Psychoactive Drugs. 2005; 37(3):333-9. DOI: 10.1080/02791072.2005.10400528. View

14.

Day C, Nassirimanesh B, Shakeshaft A, Dolan K . Patterns of drug use among a sample of drug users and injecting drug users attending a General Practice in Iran. Harm Reduct J. 2006; 3:2. PMC: 1397809. DOI: 10.1186/1477-7517-3-2. View

15.

Darke S . Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998; 51(3):253-63; discussion 267-8. DOI: 10.1016/s0376-8716(98)00028-3. View

16.

Vazirian M, Nassirimanesh B, Zamani S, Ono-Kihara M, Kihara M, Ravari S . Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: a cross-sectional study. Harm Reduct J. 2005; 2:19. PMC: 1266391. DOI: 10.1186/1477-7517-2-19. View

17.

de Saxe Zerden L, Marilis Lopez L, Lundgren L . Needle sharing among Puerto Rican injection drug users in Puerto Rico and Massachusetts: place of birth and residence matter. Subst Use Misuse. 2010; 45(10):1605-22. DOI: 10.3109/10826081003682842. View

18.

VanderWeele T . On the relative nature of overadjustment and unnecessary adjustment. Epidemiology. 2009; 20(4):496-9. DOI: 10.1097/EDE.0b013e3181a82f12. View

19.

Sharif M, Sherif A, Sayyah M . Frequency of HBV, HCV and HIV infections among hospitalized injecting drug users in Kashan. Indian J Sex Transm Dis AIDS. 2011; 30(1):28-30. PMC: 3168036. DOI: 10.4103/0253-7184.55477. View

20.

Falster K, Kaldor J, Maher L . Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004. J Urban Health. 2008; 86(1):106-18. PMC: 2629525. DOI: 10.1007/s11524-008-9330-7. View